147 related articles for article (PubMed ID: 26764105)
1. Physicochemical characterization and in vivo evaluation of triamcinolone acetonide-loaded hydroxyapatite nanocomposites for treatment of rheumatoid arthritis.
Jafari S; Maleki-Dizaji N; Barar J; Barzegar-Jalali M; Rameshrad M; Adibkia K
Colloids Surf B Biointerfaces; 2016 Apr; 140():223-232. PubMed ID: 26764105
[TBL] [Abstract][Full Text] [Related]
2. Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: In vitro and in vivo evaluations.
Jafari S; Maleki-Dizaji N; Barar J; Barzegar-Jalali M; Rameshrad M; Adibkia K
Eur J Pharm Sci; 2016 Aug; 91():225-35. PubMed ID: 27189528
[TBL] [Abstract][Full Text] [Related]
3. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations.
Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S
Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188
[TBL] [Abstract][Full Text] [Related]
4. Triamcinolone-loaded glutaraldehyde cross-linked chitosan microspheres: prolonged release approach for the treatment of rheumatoid arthritis.
Dhanaraju MD; Elizabeth S; Gunasekaran T
Drug Deliv; 2011 Apr; 18(3):198-207. PubMed ID: 21028952
[TBL] [Abstract][Full Text] [Related]
5. Ceria-containing uncoated and coated hydroxyapatite-based galantamine nanocomposites for formidable treatment of Alzheimer's disease in ovariectomized albino-rat model.
Wahba SM; Darwish AS; Kamal SM
Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():151-63. PubMed ID: 27157738
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous superparamagnetic hydroxyapatite nanocomposite: A multifunctional platform for synergistic targeted chemo-magnetotherapy.
Izadi A; Meshkini A; Entezari MH
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():27-41. PubMed ID: 31029320
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis.
Guo D; Li Q; Sun Y; Guo J; Zhao Q; Yin X; Wei H; Wu S; Bi H
Nanotechnology; 2019 Apr; 30(16):165702. PubMed ID: 30641491
[TBL] [Abstract][Full Text] [Related]
8. Triamcinolone acetonide-Eudragit(®) RS100 nanofibers and nanobeads: Morphological and physicochemical characterization.
Payab S; Davaran S; Tanhaei A; Fayyazi B; Jahangiri A; Farzaneh A; Adibkia K
Artif Cells Nanomed Biotechnol; 2016; 44(1):362-9. PubMed ID: 25180944
[TBL] [Abstract][Full Text] [Related]
9. Application of hydroxyapatite nanoparticles in development of an enhanced formulation for delivering sustained release of triamcinolone acetonide.
Koocheki S; Madaeni SS; Niroomandi P
Int J Nanomedicine; 2011; 6():825-33. PubMed ID: 21589650
[TBL] [Abstract][Full Text] [Related]
10. The effect of the androstane lung cancer inhibitor content on the cell-selective toxicity of hydroxyapatite-chitosan-PLGA nanocomposites.
Ignjatović NL; Penov-Gaši KM; Ajduković JJ; Kojić VV; Marković SB; Uskoković DP
Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():371-377. PubMed ID: 29752109
[TBL] [Abstract][Full Text] [Related]
11. Nanocomposites of bacterial cellulose/hydroxyapatite for biomedical applications.
Grande CJ; Torres FG; Gomez CM; Bañó MC
Acta Biomater; 2009 Jun; 5(5):1605-15. PubMed ID: 19246264
[TBL] [Abstract][Full Text] [Related]
12. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
Chen M; Li X; Liu J; Han Y; Cheng L
J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
[TBL] [Abstract][Full Text] [Related]
13. Fabrication of Gentamicin-Loaded Hydroxyapatite/Collagen Bone-Like Nanocomposite for Anti-Infection Bone Void Fillers.
Oshima S; Sato T; Honda M; Suetsugu Y; Ozeki K; Kikuchi M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952242
[TBL] [Abstract][Full Text] [Related]
14. New core-shell hydroxyapatite/Gum-Acacia nanocomposites for drug delivery and tissue engineering applications.
Padmanabhan VP; Kulandaivelu R; Nellaiappan SNTS
Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():685-693. PubMed ID: 30184795
[TBL] [Abstract][Full Text] [Related]
15. Biodegradation and cytotoxicity of ciprofloxacin-loaded hydroxyapatite-polycaprolactone nanocomposite film for sustainable bone implants.
Nithya R; Meenakshi Sundaram N
Int J Nanomedicine; 2015; 10 Suppl 1(Suppl 1):119-27. PubMed ID: 26491313
[TBL] [Abstract][Full Text] [Related]
16. Agarose encapsulated mesoporous carbonated hydroxyapatite nanocomposites powder for drug delivery.
Kolanthai E; Abinaya Sindu P; Thanigai Arul K; Sarath Chandra V; Manikandan E; Narayana Kalkura S
J Photochem Photobiol B; 2017 Jan; 166():220-231. PubMed ID: 28012416
[TBL] [Abstract][Full Text] [Related]
17. Influence of selected variables on fabrication of Triamcinolone acetonide loaded solid lipid nanoparticles for topical treatment of dermal disorders.
Pradhan M; Singh D; Singh MR
Artif Cells Nanomed Biotechnol; 2016; 44(1):392-400. PubMed ID: 25229831
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyapatite/sericin composites: A simple synthesis route under near-physiological conditions of temperature and pH and preliminary study of the effect of sericin on the biomineralization process.
Veiga A; Castro F; Reis CC; Sousa A; Oliveira AL; Rocha F
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110400. PubMed ID: 31923995
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of physicochemical characterization of nanocomposites on Ag
Jebapriya M; Venkatesan R; Ansar S; Kim SC
Colloids Surf B Biointerfaces; 2023 Sep; 229():113463. PubMed ID: 37481804
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyapatite-TiO(2)-based nanocomposites synthesized in supercritical CO(2) for bone tissue engineering: physical and mechanical properties.
Salarian M; Xu WZ; Wang Z; Sham TK; Charpentier PA
ACS Appl Mater Interfaces; 2014 Oct; 6(19):16918-31. PubMed ID: 25184699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
